A Proof of Concept Pilot Study of the Addition of Venetoclax to Standard Remission Induction Chemotherapy Fludarabine or Cladrabine, Cytarabine, and Granulocyte Colony Stimulating Factor (G-CSF) (FLAG or CLAG) for Frontline Therapy of Secondary Acute Myeloid Leukemia

Clinical trial NCT05780879 · TERMINATED

Trial details

NCT number: NCT05780879
Sponsor: University of Michigan Rogel Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Secondary Acute Myeloid Leukemia

Start date: 2024-06-03
Primary completion: 2025-08-16
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.